Sign Up for Our E-Newsletter

Spotlight

Lee-Undy-with-Linda

We’re excited to announce we’ve teamed up with Lee Silverstein, creator and host of The Colon Cancer Podcast! Did you know people in 46 states … read more

Our Heroes

bluestar_small

Exciting news! We’ve welcomed two new Board of Directors members to the Colon Cancer Alliance family this month. These professionals bring unique expertise, connection to … read more

What's Happening?

microscope-275984_640

Last month, we traveled to Chicago to attend the American Society of Clinical Oncology’s (ASCO) Annual Meeting. This is where the top up-and-coming cancer research … read more

Board of Directors: Welcome to Our 2 Newest Members

Posted on July 1, 2015

bluestar_small

Exciting news! We’ve welcomed two new Board of Directors members to the Colon Cancer Alliance family this month. These professionals bring unique expertise, connection to the cause and commitment to our vision for a world free of colon cancer. We look forward to seeing their fresh perspectives come to life as they join our Board of dedicated leaders and take us steps closer to knocking out colon cancer.

Meet Riccardo de Marchi Trevisan and Tess Fraser.                                                  

Read more

Welcome Jenni Wojnar, Special Event Manager

Posted on June 30, 2015

Jenni

It’s our pleasure to introduce our new Special Event Manager Jenni Wojnar! Jenni is bringing her passion for fundraising and non-profit work to the Undy team and we’re so excited to have her join the Colon Cancer Alliance family. Learn a little more about Jenni and help us welcome her!

Read more

Top 5: Need to Know About Young Onset Colon Cancer

Posted on June 26, 2015

N2Y

Our Conversations Webinar Series is an opportunity to link national experts in colorectal cancer and other related fields to you, right in the comfort of your own home. The programs are designed to empower you to play a leading role in your healthcare management.

On June 16, we hosted “My Story: Colon Cancer Before 50” as part of the Never Too Young Coalition’s Young Survivors Week. We heard from four young survivors and Dr. Christopher Lieu, who informed us about this rising trend, including signs, symptoms and the importance of family history.

If you couldn’t make the webinar, you’re in luck! Here are the top 5 takeaways, along with the replay: 

Read more

Promising Drug from ASCO Now Accepting Applicants for New Study

Posted on June 25, 2015

microscope-275984_640

Last month, we traveled to Chicago to attend the American Society of Clinical Oncology’s (ASCO) Annual Meeting. This is where the top up-and-coming cancer research from the year is presented to more than 25,000 experts, advocates, doctors, researchers and scientists from around the world. Our very own Dr. Laura Porter attended and has been keeping a close eye as studies and information have continued to be released. When it was announced that one of the most exciting experimental drugs would be accepting applicants for a new study, she immediately flagged this as something we needed to get out ASAP.

Here’s what you need to know:

One of the most exciting presentations from ASCO was the results of a clinical trial for a new colorectal cancer drug called pembrolizumab (Keytruda). This drug was hailed as a breakthrough for a subset of patients with metastatic colorectal cancer (mCRC). Pembrolizumab is a monoclonal antibody, which means it works to restore the body’s immune response to tumor cells, enabling a patient’s own body to kill the cancer. Read more

View all posts

css.php